Snell & Wilmer has advised Traws Pharma, Inc. Traws Pharma, Inc. (Nasdaq: TRAW), a clinical-stage biopharmaceutical company, has entered into a securities purchase agreement with new...
-
Follow Us
-
Search
- North America
- Latin America
- Europe
September 25, 20264The Exploration Company Raises $450 Million in Series C Financing for Space Expansion
September 25, 20264PKO Bank Polski Issues €500 Million Senior Non-Preferred Green Notes
September 25, 20264Orgvue Acquired by Main Capital Partners
- Africa
- Middle East
- Asia & Pacific
September 25, 20264Copenhagen Infrastructure Partners Acquires and Secures Project Financing for Gawara Baya Hybrid Project
September 25, 20264RBL Bank Establishes US$1bn Euro Medium Term Note Programme and Completes Inaugural US$350m Issuance
September 25, 20264Bharat Forge Completes ?2,000 Crore Qualified Institutions Placement
- Editorials
September 25, 20264Pachulski Stang Ziehl & Jones Elects Bradford Sandler as the Firm’s First Chair
September 24, 20264Lowenstein Sandler Names Marie T. DeFalco and Sara R. Werner Co-chairs of Venture Funds Launch Group
September 23, 20264Finn Dixon & Herling Names Claire Stevens as Chair of Investment Management Practice
- In & Out
September 25, 20264Mayer Brown expands premier finance platform with addition of leveraged finance and private credit partner Kerrick Seay in New York
September 25, 20264O’Melveny Expands Bankruptcy & Restructuring Team with Leading Corporate Restructuring Lawyer Penelope Jensen
September 24, 20264Milbank Strengthens Tax Practice with the Addition of Leading Tax Lawyer Alex Anderson